文献速递物质与行为成瘾心境障碍精神分裂症与精神病性障碍

2005至2019年美国退伍军人共病人群大麻使用障碍患病率趋势

Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019.
PubMed 文献 · Am J Psychiatry · 2023-11-29

该研究利用退伍军人健康管理局2005至2019年电子健康记录,分析伴有抑郁、焦虑、创伤后应激、双相或精神病性谱系障碍患者的大麻使用障碍患病率趋势,并与无这些障碍的患者比较。结果显示,精神障碍患者的大麻使用障碍患病率增幅更大,且在年轻和老年亚组中呈现不同模式,双相和精神病性谱系障碍患者增幅最大。

要点

  • 精神障碍患者大麻使用障碍患病率增幅显著高于无精神障碍者。
  • 2005-2014年小于35岁患者增幅最大,2016-2019年65岁及以上患者增幅最大。
  • 双相和精神病性谱系障碍患者的大麻使用障碍患病率增幅最大。

核心结论

  • 退伍军人健康管理局患者中,伴有常见精神障碍者的大麻使用障碍患病率增长幅度不成比例地高于无精神障碍者。

研究设计与样本

  • 基于退伍军人健康管理局2005至2019年电子健康记录,样本量范围为4,332,165至5,657,277,按年龄组和是否伴有精神障碍分析大麻使用障碍诊断患病率趋势,并分2005-2014(ICD-9-CM)和2016-2019(ICD-10-CM)两个时期检验趋势差异。

主要发现

  • 精神障碍患者相比无精神障碍者,大麻使用障碍患病率变化差值在2005-2014年为1.91%(95% CI=1.87-1.96),在2016-2019年为0.34%(95% CI=0.29-0.38)。
  • 2005至2014年间,小于35岁精神障碍患者的大麻使用障碍患病率不成比例增长最显著。
  • 2016至2019年间,65岁及以上精神障碍患者的大麻使用障碍患病率不成比例增长最显著。
  • 在精神障碍患者中,双相和精神病性谱系障碍患者的大麻使用障碍患病率增幅最大。

临床怎么用

  • 临床应监测、预防和治疗精神障碍患者中的大麻使用障碍,尤其关注年轻及老年患者以及双相和精神病性谱系障碍患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cannabis use disorder diagnoses are increasing among U.S. adults and are more prevalent among people with comorbid psychiatric disorders. Recent changes in cannabis laws, increasing cannabis availability, and higher-potency cannabis may have placed people with cannabis use and psychiatric disorders at disproportionately increasing risk for cannabis use disorder. The authors used Veterans Health Administration (VHA) data to examine whether trends in cannabis use disorder prevalence among VHA patients differ by whether they have psychiatric disorders. METHODS: VHA electronic health records from 2005 to 2019 (N range, 4,332,165-5,657,277) were used to identify overall and age-group-specific (<35, 35-64, and ≥65 years) trends in prevalence of cannabis use disorder diagnoses among patients with depressive, anxiety, posttraumatic stress, bipolar, or psychotic spectrum disorders and to compare these to corresponding trends among patients without any of these disorders. Given transitions in ICD coding, differences in trends were tested within two periods: 2005-2014 (ICD-9-CM) and 2016-2019 (ICD-10-CM). RESULTS: Greater increases in prevalence of cannabis use disorder diagnoses were observed among patients with psychiatric disorders compared to those without (difference in prevalence change, 2005-2014: 1.91%, 95% CI=1.87-1.96; 2016-2019: 0.34%, 95% CI=0.29-0.38). Disproportionate increases in cannabis use disorder prevalence among patients with psychiatric disorders were greatest among those under age 35 between 2005 and 2014, and among those age 65 or older between 2016 and 2019. Among patients with psychiatric disorders, the greatest increases in cannabis use disorder prevalences were observed among those with bipolar and psychotic spectrum disorders. CONCLUSIONS: The findings highlight disproportionately increasing disparities in risk of cannabis use disorder among VHA patients with common psychiatric disorders. Greater public health and clinical efforts are needed to monitor, prevent, and treat cannabis use disorder in this population.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Livne O, Malte CA, Olfson M, et al. Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019. Am J Psychiatry. 2023. PMID: 38018141. doi:10.1176/appi.ajp.20230168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。